Mirus Bio Introduces the NEW Quality Tested TransIT-VirusGEN® SELECT Transfection Reagent Designed for the Drug Discovery Pipeline in Gene and Cell Manufacturing
Madison, Wis. (July 25, 2019) ‒ The TransIT-VirusGEN® SELECT Transfection Reagent is developed for large-scale virus production for preclinical and early phase clinical trials and is identical